ABBISKO-B (02256) repurchased 60,000 shares on October 27 for HK$401,000.
ABBISKO-B (02256) announced that on October 27, 2026, the company repurchased 60,000 shares for HK$401,000, at a repurchase price of HK$6.52-6.94 per share.
ABBISKO-B (02256) announced that on October 27, 2026, the company repurchased 60,000 shares for HK$401,000, at a repurchase price of HK$6.52-6.94 per share.
Related Articles
CSPC PHARMA (01093): Results of the Phase I/II Clinical Study of the Anti-PD-1/IL-15 Bifunctional Fusion Protein SYS6090 (JMT108) as Monotherapy for Advanced Solid Tumors Presented as a Rapid Oral Presentation at the 2026 ESMO Congress
GLOBAL NEW MAT (06616): Chen Xi Appointed as Joint Company Secretary
DMALL (02586) repurchased 295,100 shares on October 27 for approximately HK$2.504 million.
CSPC PHARMA (01093): Results of the Phase I/II Clinical Study of the Anti-PD-1/IL-15 Bifunctional Fusion Protein SYS6090 (JMT108) as Monotherapy for Advanced Solid Tumors Presented as a Rapid Oral Presentation at the 2026 ESMO Congress
GLOBAL NEW MAT (06616): Chen Xi Appointed as Joint Company Secretary
DMALL (02586) repurchased 295,100 shares on October 27 for approximately HK$2.504 million.
